Who we are
The IFMRS is an international, not for profit federation of musculoskeletal research societies dedicated to promoting excellence in the field of bone and mineral research. The IFMRS mission is to advance musculoskeletal research globally in order to prevent and treat musculoskeletal diseases by collaborating with international societies to share resources, raise public awareness and provide education.
Our Mission
The mission of the IFMRS is to advance musculoskeletal research globally in order to prevent and treat musculoskeletal diseases by collaborating with international societies to share resources, raise public awareness and provide education.
The IFMRS activities over the next couple of years will focus on:
- Expanding the Big Data project
- Developing an on-line learning environment HubLE
- Opening membership to all musculoskeletal disciplines
- Increasing exposure for all member societies through social media, joint sessions at meetings, and development of the website
- Developing education programmes for extending into emerging countries
Leadership - IFMRS Board of Directors
Roland Baron DDS, PhD
IFMRS Co-Chair
Bente Langdahl MD, DMSc
IFMRS Co-Chair
Markus Seibel MD, PHD, FRACP
IFMRS Treasurer
D. Rick Sumner PhD
IFMRS Secretary
Nicola Napoli
The American Society for Bone and Mineral Research (ASBMR)
Gudrun Stenbeck
European Calcified Tissue Society (ECTS)
Mark Forwood
The Australia and New Zealand Bone and Mineral Society (ANZBMS)
Ling Qin
International Chinese Musculoskeletal Research Society (ICMRS)
Seiji Fukomoto
Japanese Society for Bone and Mineral Research (JSBMR)
Jennifer Westondorf
Orthopaedic Research Society (ORS)
Juan Jose Scali (IFMRS representative)
The Iberoamerican Society of Osteology and Mineral Metabolism (SIBOMM)
Robert Blank
The International Society for Clinical Densitometry (ISCD)
Manuel Naves Díaz
Sociedad Española de Investigación Ósea y Metabolismo Mineral (SEIOMM)
Ramiro da Silva (SIBOMM President) – non-Director
The Iberoamerican Society of Osteology and Mineral Metabolism (SIBOMM)
Scott Byrne
Molecular & Experimental Pathology Society of Australasia (MEPSA)
Egon Perilli
Australian and New Zealand Orthopaedic Research Society (ANZORS)
Ralph Müller
International Society of Bone Morphometry (ISBM)
Claire Edwards
Cancer and Bone Society (CABS)
IFMRS Committees and Working Groups
Future Global Leaders
Julie Anne Sterling (ASBMR) Co-Chair
Karl Lewis (ORS) Co-Chair
Xiaowei Sherry Liu (ICMRS)
Toshihide Mizoguchi (JSBMR)
Tania Winzenberg (ANZBMS)
Meghan Lawrence (ASBMR)
Nicolas Bonnet (ECTS)
Education Working Group
Mark Forwood (ANZBMS) Chair
Karl Lewis (ORS)
Gudrun Stenbeck (ECTS)
Robert Blank (ISCD)
Nicolas Bonnet (ECTS)
Big Data Working Group
ASBMR (American Society for Bone and Mineral Research)
Lynda Bonewald (Co-chair)
Jane Lian
Doug Kiel
David Karasik
ANZBMS (Australia and New Zealand Bone and Mineral Society)
Emma Duncan (Co-chair)
John Kemp
European Calcified Tissue Society (ECTS)
Fernando Rivadeneira
International Chinese Musculoskeletal Research Society (ICMRS)
Jian Li
Qing Wu
Japanese Society of Bone and Mineral Research (JSBMR)
Yuuki Imai
Yoshiya Tanaka
Ibero American Society of Osteology and Mineral Metabolism (SIBOMM)
Merce Giner
Aranzazu Rodriguez de Gortázar Alonso-Villalobos
Orthopaedic Research Society (ORS)
Nidhi Bhutani
Muhammad Farooq Rai
Jennifer Westendorf
Elizabeth Yanik
International Society for Bone Morphometry
Ralph Müller
MUSCULOSKELETAL KNOWLEDGE PORTAL
Big Data Sub-Group
CHAIR – Douglas Kiel (Big Data Group member/ASBMR)
Lynda Bonewald (Big Data Group co-chair/ASBMR)
Emma Duncan (Big Data Group co-chair/ANZBMS)
Fernando Rivadeneira (ECTS)
Yuuki Imai (JSBMR)
Jennifer Westendorf (ORS)
David Karasik (ASBMR)
Ralph Muller (ISBM)
John Kemp (University of Queensland)
Staff
990 Forms
Federico Moscogiuri
IFMRS CEO
Email: ceo (at) ifmrs.org
Return of Organization Exempt From Income Tax Forms (990). To view or download the relevant form please click on a link below
Corporate Support
The benefits of Corporate Support
- increase membership to ensure global representation
- raise global awareness of musculoskeletal medical and scientific issues through collaborative endeavors amongst member organizations
- expand the website to provide up-to-date and relevant information on events, grants, research and opportunities and provide a central resource for researchers with an interest in musculoskeletal and related topics via HubLE
- develop the musculoskeletal genomics knowlegde portal
- develop an education programme specific to emerging countries – a programme of topics and IFMRS speakers will be available for presenting in countries requiring up to date information on current research and clinical issues relating to musculoskeletal topics
- ensure members have access to grants and awards:
– provide information on existing and upcoming grant opportunities
– offer IFMRS-specific grants to enable young researchers to spend time in another laboratory to learn new techniques
– collaborate with all member societies to develop an extensive grants and awards programme for the future
Summary of benefits:
- Company profile on IFMRS website
- Acknowledgement at any joint events and/or sessions
- Company logo and acknowledgement at any IFMRS Training/Education event
- Raising awareness worldwide on current issues relevant to the musculoskeletal field
- Mailing to all IFMRS members to advertise any satellite session booked for joint meetings
- Additional access may be available, depending on each member society’s policy and country data protection rules
- Attendance at KOL meeting during member society’s annual congress – It is important to us that we hear your views so that we can work together to ensure that the needs of our members are met. Meetings will be arranged during the ASBMR annual congress to discuss future activities and opportunities for collaborative projects.
- Regular updates on IFMRS activities
Corporate Partners
We are grateful to our Corporate Partners:
Kyowa Kirin
Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies. www.kyowakirin.com
Ipsen
Ipsen is a global biopharmaceutical company dedicated to improving lives through innovative medicines in Oncology, Neuroscience and Rare Diseases. In Rare Diseases, Ipsen is committed to making high-quality, innovative therapeutic treatments available to people with rare diseases and supporting them and their families with medicines, services and solutions across the entire continuum of care, from diagnosis to treatment follow-up. Its goal is to leave no patient behind. Ipsen has a global presence and capabilities to serve patients around the world: with medicines available in 120 countries and a direct commercial presence in more than 30 countries. For more information on Ipsen, visit www.ipsen.com